© Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.
Filing date | Form | Description | View |
---|---|---|---|
D | View HTML | ||
10-12G | A general registration filing of securities pursuant to section 12(g) of the Securities Exchange Act |
View HTML | |
PRE 14A | A preliminary proxy statement providing notification matters to be brought to a vote |
View HTML | |
PRE 14A | A preliminary proxy statement providing notification matters to be brought to a vote |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML |
Data provided by Kaleidoscope.
© Travere Therapeutics, Inc. All rights reserved. For US audiences. Chenodal®, Cholbam® and Total Care HUB® are registered trademarks of Travere Therapeutics, Inc. Thiola® and Thiola EC® are registered trademarks of Mission Pharmacal Company.